40
Participants
Start Date
June 11, 2025
Primary Completion Date
January 31, 2027
Study Completion Date
August 31, 2027
Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]
Individuals will receive a full course (i.e., 84 tablets) of Sofosbuvir / Velpatasvir 400/100mg tablets.
Community Health Worker
Participants will receive support from a Community Health Worker which may include assistance with basic needs (transportation, housing, employment, vital documents, insurance re-activation) as well as medication adherence, patient navigation, and peer recovery support.
RECRUITING
Rhode Island Department of Corrections, Cranston
National Institute on Drug Abuse (NIDA)
NIH
Lifespan
OTHER